Name
ALCOHOLIC CIRRHOSIS
DESCRIPTION
DETAIL
D.D. - * INFECTIONS LIKE HEPATITIS B, C & D DISEASE BRUCELLOSIS CAPILLARIASIS ECHINOCOCCOSIS TOXOPLASMOSIS CYTOMEGALOVIRUS EPSTEIN BARR VIRUS SYPHILIS SCHISTOSOMIASIS * CHR ACTIVE HEPATITIS - LUPOID HEPATITIS ( AUTOIMMUNE CHR ACTIVE HEPATITIS ) - DRUGS LIKE ANTICONVULSANTS, OXYPHENACETIN, METHYLDOPA & ANTITUBERCULAR, AMIORADONE, ARSENICALS, ORAL CONTRACEPTIVES, * GENETIC DEFECTS - HAEMACHROMATOSIS WILSONS DISEASE GALACTOSAEMIA GLYCOGEN STORAGE DISEASES ALPHA-1 ANTITRYPSIN DEFICIENCY ALAGILLES SYNDROME FANCONI SYNDROME GAUCHERS DISEASE HERIDITARY FRUCTOSE INTOLERANCE HERIDITARY TYROSINEMIA * BILIARY DISEASES - LONG STANDING EXTRAHEPATIC BILIARY OBSTRUCTION PRIMARY BILIARY CIRRHOSIS SCLEROSING CHOLANGITIS CONGENITAL HEPATIC FIBROSIS BILIARY ATRESIA FAMILIAL INTRAHEPATIC CHOLESTASIS * VENOUS CONGESTION - CARDIAC FAILURE CONSTRICTIVE PERICARDITIS BUDD-CHIARI SYNDROME * JEJUNO-ILEAL BYPASS * CYSTIC FIBROSIS * GRAFT VERSUS HOST DISEASE * NONALCOHOLIC STEATOHEPATITISOTHER TESTS - * SGPT - > 300 UNITS ARE UNUSUAL & MAY BE DUE TO SOME OTHER CAUSE THAN ALCOHOL * ANEMIA & FOLIC , VIT B-12 DEFICIENCY * AST / ALT RATIO > 2 ( SGOT / SGPT ) , S. ALBUMIN DECREASED, GLOBULIN INCREASED, PROTHROMBIN TIME INCREASED * S. AMMONIA - NORMAL OR INCREASED * PERCUTANEOUS NEEDLE BIOPSY OF LIVER
TYPENOTES
Medical Care: No specific medical treatment is needed for patients with alcoholic fatty liver. Steatosis usually resolves within 2 weeks of discontinuing alcohol. Abstinence and adequate diet are the mainstays in therapy for alcohol-induced steatosis. Bed rest has no proven benefit. Anabolic steroids may be detrimental. Management of patients with alcoholism and fatty liver often requires recognition and treatment of alcohol withdrawal. These patients may have deficiencies of vitamins, minerals, and trace elements. Adequate replacement of these deficiencies should be a part of management. Although alcohol-induced hyperhomocysteinemia (which has been associated with endoplasmic reticulum stress leading to apoptosis and up-regulation of lipid synthesis) and its correction by betaine have been studied in animal models, no definite role of the use of betaine in alcoholic fatty liver in humans is available.
RELATED DISEASE
Not Available Disease
DISEASE
INVESTIGATION
PROTHROMBIN TIME, SERUM AMMONIA, COMPLETE BLOOD COUNT, LIVER FUNCTION TEST, BIOPSY